Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-26
2010-06-08
Solola, Taofiq A (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07732626
ABSTRACT:
The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof. The compound or a salt thereof or a prodrug thereof has a GPR40 receptor function modulating action and is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.
REFERENCES:
patent: 2004/0102634 (2004-05-01), Matsuura et al.
patent: 2006/0258722 (2006-11-01), Yasuma et al.
patent: 2007/0105959 (2007-05-01), Kusuda et al.
patent: 2008/0188502 (2008-08-01), Burrows et al.
patent: 2008/0269220 (2008-10-01), Yasuma et al.
patent: 2009/0170894 (2009-07-01), Aletru et al.
patent: 2009/0176775 (2009-07-01), Braun et al.
patent: 1 559 422 (2005-08-01), None
patent: 1 630 152 (2006-03-01), None
patent: 1 698 624 (2006-09-01), None
patent: 1 726 580 (2006-11-01), None
patent: 1 731 505 (2006-12-01), None
patent: 2003-261491 (2003-09-01), None
patent: 00/64876 (2000-11-01), None
patent: 01/14358 (2001-03-01), None
patent: 2004/041266 (2004-05-01), None
patent: 2004/091604 (2004-10-01), None
patent: 2004/106276 (2004-12-01), None
patent: 2005/063729 (2005-07-01), None
patent: 2005/087710 (2005-09-01), None
Examiner's Report and an English translation thereof issued in the corresponding Chilean Patent Application No. 1873-2007.
International Search Report issued Jul. 17, 2009 in the International (PCT) Application of which the present application is the U.S. National Stage. PCT/JP2007/063208.
X. Cui et al., “Catalytic Homogeneous Asymmetric Hydrogenations of Largely Unfunctionalized Alkenes”, Chemical Reviews, vol. 105, No. 9, pp. 3272-3296, 2005.
P. Barbaro et al., “Progress in stereoselective catalysis by metal complexes with chiral ferrocenyl phosphines”, Coordination Chemistry Reviews, vol. 248, No. 21-24, pp. 2131-2150, Dec. 1, 2004.
M. J. Burk et al., “Modular Phospholane Ligands in Asymmetric Catalysis”, Accounts of Chemical Research, vol. 33, No. 6, pp. 363-372, 2000.
P. Bravo et al., “Electron Impact Mass Spectrometry of Some 2,3-Dihydro-1-benzofuran-3-acetic Acids,” Organic Mass Spectrometry, vol. 20, No. 1, pp. 53-57, 1985.
Bravo, Pierfrancesco et al., “Electron Impact Mass Spectrometry of Some 2, 3-Dihydro-1-benzofuran-3-acetic Acids,” Organic Mass Spectrometry, 1985, vol. 20, No. 1, pp. 53-57.
Haeflinger, Walter von et al., “Stereospezifische Synthese einer neuen Morphin-Teilstruktur,” Helvetica Chemica Acta, 1982, vol. 65, No. 6, pp. 1837-1852.
Communication Relating to the Results of the Partial International Search (Form PCT/ISA/206) in International Application No. PCT/JP2007/063208.
Itou Masahiro
Negoro Nobuyuki
Yamashita Masayuki
Yasuma Tsuneo
Solola Taofiq A
Takeda Pharmaceutical Company Limited
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Fused cyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused cyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused cyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4244493